An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older
| Publicado en: | Drug Safety Vol. 47; no. 4; pp. 365 - 376 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Apr2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176181459&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 176181459 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01145916 C5E jtl: Drug Safety issn: 01145916 maglogo: N pubinfo: dt: Apr2024 vid: 47 iid: 4 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 176181459 176021192 10.1007/s40264-024-01395-8 176181459 ppf: 365 ppct: 11 formats: tig: atl: An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older aug: au: Dos Santos, Gaël Devadiga, Raghavendra Kim, Chun Soo Bang, Joon affil: GSK, Wavre, Belgium sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|